Journal for ImmunoTherapy of Cancer (Feb 2022)
ISA101 and nivolumab for HPV-16+ cancer: updated clinical efficacy and immune correlates of response
- Jing Wang,
- Lei Feng,
- Qi Wang,
- Erminia Massarelli,
- Renata Ferrarotto,
- Michael A Curran,
- Jack Lee,
- Ignacio Wistuba,
- Cornelis J M Melief,
- Bonnie S Glisson,
- Kimal Rajapakshe,
- Cristian Coarfa,
- William William,
- Luana Guimaraes de Sousa,
- Jaime Rodriguez Canales,
- Renee L Chin,
- Tomas Z Barrese,
- Faye M Johnson
Affiliations
- Jing Wang
- College of Nursing, Florida State University, Tallahassee, Florida, USA
- Lei Feng
- 19 Radiology, Kaiser Permanente LAMC, Los Angeles, California, USA
- Qi Wang
- Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada
- Erminia Massarelli
- Aff23 grid.240145.60000000122914776University of Texas MD Anderson Cancer Center Houston TX USA
- Renata Ferrarotto
- Department of Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- Michael A Curran
- 1 Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- Jack Lee
- Division of Biomedical Engineering and Imaging Sciences, King`s College London, London, UK
- Ignacio Wistuba
- Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- Cornelis J M Melief
- 3 ISA Pharmaceuticals, Leiden, The Netherlands
- Bonnie S Glisson
- 3 Department of Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- Kimal Rajapakshe
- 4 Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
- Cristian Coarfa
- 6 Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA
- William William
- The University of Texas MD Anderson Cancer Center, Houston, TX, United States
- Luana Guimaraes de Sousa
- The University of Texas MD Anderson Cancer Center Department of Thoracic Head and Neck Medical Oncology, Houston, Texas, USA
- Jaime Rodriguez Canales
- Translational Medicine, AstraZeneca, Gaithersburg, Maryland, USA
- Renee L Chin
- Department of Immunology and Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas, USA
- Tomas Z Barrese
- Grupo Fleury, Sao Paulo, Brazil
- Faye M Johnson
- The University of Texas MD Anderson Cancer Center Department of Thoracic Head and Neck Medical Oncology, Houston, Texas, USA
- DOI
- https://doi.org/10.1136/jitc-2021-004232
- Journal volume & issue
-
Vol. 10,
no. 2
Abstract
No abstracts available.